James Patrick Kelly insider trades

Open-market stock purchases and sales by James Patrick Kelly, EVP, CFO and Treasurer at Novavax Inc, from SEC Form 4 filings since Feb 18, 2010.

Recent trades

DateStockTradeValue
Mar 7, 2026NVAX Novavax IncSold (not open market)$58.9K
Mar 7, 2026NVAX Novavax IncBought (not open market)—
Mar 3, 2026NVAX Novavax IncSold (not open market)$198K
Mar 3, 2026NVAX Novavax IncBought (not open market)—
Mar 2, 2026NVAX Novavax IncBought (not open market)—
Mar 2, 2026NVAX Novavax IncBought (not open market)$1.8M
Mar 2, 2026NVAX Novavax IncBought (not open market)—
Mar 1, 2026NVAX Novavax IncBought (not open market)—
Mar 1, 2026NVAX Novavax IncSold (not open market)$288K
Mar 1, 2026NVAX Novavax IncSold (not open market)—

Companies traded

  • NVAX Novavax Inc: other filings, last Mar 7, 2026
  • SUPN Supernus Pharmaceuticals, Inc: other filings, last Feb 19, 2021
  • VNDA Vanda Pharmaceuticals Inc: 1 buy, 10 sales, last Mar 3, 2020
  • CBT Cabot Corp: 14 sales, last Dec 31, 2019

Get free alerts when James Patrick Kelly files a new trade →